Review of Indian Working Requirements

This newsletter (attached¬†below)¬†from a leading Indian firm, contains a good review of the perils of the working requirement in India. It also provides a good summary of three recent decisions holding pharma patents invalid for obviousness. What is striking is that the judicial hostility in India to “add-on” drug patents now seems reflected in recent Fed. Cir. opinions that are “anti-patent,” at least as considered by the innovator companies.

IPR_Amicus_August_2013

This entry was posted in Int'l Practice and Policy and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *